MedPath

Neurodevelopmental Therapy-Bobath Approach in The Early Term of Stroke; Safe and Effective

Not Applicable
Completed
Conditions
Stroke, Acute
Ischemic Stroke
Interventions
Other: Standart Rehabilitation Group (SR group)
Other: Neurodevelopmental Therapy-Bobath group
Registration Number
NCT03602326
Lead Sponsor
Gokhan Yazici
Brief Summary

Early term rehabilitation initiated after stroke should be based on motor learning principles and neural plasticity. To achieve motor learning and neural plasticity, exercises consisting of intense and repetitive training should be given according to the patients' functional level. The neurodevelopmental treatment-Bobath (NDT_B) approach is based on motor learning principles. In literature, studies that show the early term effects of NDT-B on functional recovery are inadequate. The aim of this study was to investigate the effects NDT-B applied in the early term of stroke, on postural control, functional movement, balance and activities of daily living.

Detailed Description

When literature is examined, it can be seen that evidence is limited. Studies investigating the effects of the Bobath Approach in the early term in stroke, state that NDT-B is reliable and feasible. However none of these studies have examined the effects of NDT-B in acute term stroke on functionality and daily living. Additionally, in all of these studies it was also stated that further studies should be conducted.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • Patients older than 18 years of age
  • Systolic blood pressure between 120 and 220 mmHg
  • Oxygen saturation >92% (with or without O2 support)
  • A heart rate of 40 to 100 beats/min
  • A body temperature of <38.5°C
  • A disability level of ≤4 according to the Modified Rankin Scale
  • Those who could respond to verbal commands
Exclusion Criteria
  • A history of previous stroke
  • Concomitant progressive neurological disturbances
  • Acute coronary disease
  • Severe heart failure
  • Concomitant rheumatologic diseases
  • A fracture or an acute orthopedic disorder that would prevent mobilization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standart Rehabilitation Group (SR group)Standart Rehabilitation Group (SR group)Patients will be included in standard rehabilitation sessions, 5 days per week. The rehabilitation sessions will be performed by standard clinical physiotherapists according to the hospital routine. The rehabilitation program will consist of in-bed joint range of motion exercises and bedside mobilization applications. The patients will be included in the rehabilitation program as early as possible and the program will continue until the patients are discharged
Neurodevelopmental Therapy-Bobath groupNeurodevelopmental Therapy-Bobath groupBobath Approach Principles and exercises will be performed 5 days a week with physical therapists and everyday with caregivers. Physiotherapy will be initiated as early as possible according to the principles of the method by experienced NDT-B therapists. Exercises will be implemented according to the patients' status and will be used to maintain and improve muscle strength and endurance. Both the unaffected and affected side will be included in rehabilitation. The exercises given are designed to be simple, understandable, task-oriented and repetitive, in accordance with the Bobath approach and the functional state of the patient at that time. In order to prevent motor amnesia and neglect of the affected side, correct positioning and sensory input will be provided since the first session.
Primary Outcome Measures
NameTimeMethod
The Stroke Rehabilitation Assessment of Movement ScaleChange from Baseline functional movements at 10 days

The Stroke Rehabilitation Assessment of Movement Scale (STREAM) was used to assess functional movements and mobility. The scale consists of two subsections and a total of 30 tests evaluating the performance and the quality of the individual's voluntary limb movements (20 tests) and basic mobility activities (10 tests). The total score will be used for assessment in this study. The total score is 70. A high score indicates less motor impairment, while a lower score indicates increased motor impairment.

Secondary Outcome Measures
NameTimeMethod
The Berg Balance ScaleChange from Baseline functional balance at 10 days

The Berg Balance Scale (BBS) was used to assess functional balance. BBS consists of 14 tests evaluating balance during; postural changes, at different positions and during movement. Each test is rated from 0 to 4. The total score will be used for assessment in this study. The highest score is 56; 0-20 point indicates a balance disorder (high risk of falls), 21-40 points indicates an acceptable balance (moderate risk of falls), 41-56 points indicates good balance (low risk of falling)

The Functional Ambulation ClassificationChange from Baseline level of functional ambulance at 10 days

The Functional Ambulation Classification (FAC) is a method for classifying gait mobility in neurologically impaired patients. The FAC has six categories ranging from 0 to 5. A higher score indicates independence in ambulation, while a lower score indicates the person has non-functional ambulation. This 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device.

The Trunk Impairment scaleChange from Baseline sitting balance and postural control at 10 days

The Trunk Impairment scale (TIS) was used to assess sitting balance and postural control. TIS consists of 3 sections and 17 tests evaluating static-dynamic sitting balance and coordination. The total score will be used for assessment in this study. The total score is 23. A higher score indicates better control of the trunk, while a lower score indicates poor postural trunk control.

Trial Locations

Locations (1)

Gazi University Hospital, Department of Neurology

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath